Jeffrey Heitmann
Obstetrics · Naples, FLNPI 1407884034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $440 and has fallen 58.8% since, to $181 in 2025.
Across 105 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$280
- Exeltis, USA Inc.$241
- Hologic Sales And Service, LLC$202
- Pfizer$155
- Therapeuticsmd, Inc.$144
- Organon$104
- plus $684 from 19 others
What the payments were for
- Food & beverage$1,66992%
- Education$1428%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $280 |
| Exeltis, USA Inc. | 13 | $241 |
| Hologic Sales And Service, LLC | 11 | $202 |
| Pfizer | 9 | $155 |
| Therapeuticsmd, Inc. | 9 | $144 |
| Organon | 6 | $104 |
| Merck | 6 | $98 |
| Millicent US Inc | 4 | $66 |
| Bayer | 4 | $65 |
| Evofem Biosciences, Inc. | 3 | $63 |
| AMAG Pharmaceuticals, Inc. | 3 | $54 |
| Momentis Surgical Inc. | 1 | $50 |
| Mayne Pharma Commercial LLC | 3 | $45 |
| Avion Pharmaceuticals | 3 | $42 |
| Amgen | 2 | $28 |
| Innovation Technologies Inc | 1 | $24 |
| Duchesnay USA Incorporated | 1 | $21 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $17 |
| Coopersurgical, Inc. | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Lupin Inc. | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $12 |
How this compares
$1,810 in reported general payments places this provider in the 60th percentile of 78 obstetrics providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,916 |
| ProgesteroneProgesterone, Micronized | 38 | $1,690 |
| Estradiol (Once Weekly)Estradiol | 11 | $985 |
| ValacyclovirValacyclovir Hcl | 13 | $494 |
| Levothyroxine Sodium | 22 | $176 |
| Simvastatin | 15 | $81 |
| Finasteride | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Naples
- Phan NguyenNaples$14K
- Steven ShephardNaples$4K
- Su ParkerNaples$2K
- Wilkens MondesirGreenacres$16K
- Nasim KhanSebring$11K
- Ivonne ReynoldsMargate$11K
- Robert FeldmanSouth Miami$10K
- Isidro MartinezMiami$10K
- Michele LemayBradenton$10K
- Kyle GarnerSarasota$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.